Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Teddy3on Sep 27, 2021 6:25pm
92 Views
Post# 33928251

RE:RE:RE:Commencement of Trading on the OTCQB

RE:RE:RE:Commencement of Trading on the OTCQBWasn't the last reverse split done supposed to get institutional investors? Wasn't Tripp talking about the Nasdaq years ago instead of the OTQwhaterver? They launched Aristotle in Q1 and can't move the price up naturally (because there is no talent in management at all), now need a second RS so quickly again. Not even trying to bash but this company been forecasting BS for a decade and you all keep eating it up for some reason...

For Photoboy777 to highlight what he did is a complete joke and an insult to anyone following this company that is not a paid employee. 

A reverse split is just putting makeup on a truly ugly pig. Any instituion that digs into this company will not touch it just because the SP look higher. Only until they show they can sell Aristotle and grow sales. (provided its a real test that works) If this happens its many many years away.
<< Previous
Bullboard Posts
Next >>